Stage 4 Lung Cancer Stabilized: A Woman’s Journey with Sodium Phenylbutyrate Therapy (Antineoplastons)

A Mother’s Diagnosis and Limited Conventional Options

A son accompanied his mother when she was diagnosed with stage 4 lung cancer. The doctors offered conventional chemotherapy, which could extend her life expectancy to 1–1.5 years, compared to only six months without treatment. Faced with limited options, the family began researching non-conventional therapies and discovered a clinic offering Sodium phenylbutyrate and its derivatives, known as antineoplastons.

Pursuing Alternative Treatment with Sodium Phenylbutyrate

The woman began the alternative treatment, receiving Sodium phenylbutyrate therapy over the course of several months. The family remained hopeful, seeking a way to improve her condition beyond the traditional options.

Encouraging Results and Renewed Hope

During a follow-up visit with imaging tests, the results were promising: the lung tumors had stabilized, and some had even shrunk. The outcome surprised her doctors, giving the family renewed hope. This unexpected improvement encouraged them to continue the therapy, aiming to extend her life and enhance her quality of life.

“My mom has been put on the treatment and within a month and a half, the cancer was stable and some of the tumor actually started to shrink.“

— Mr. Fizli, son of a mother suffering from lung cancer

Scroll to Top